Voss M D, Beha A, Tennagels N, Tschank G, Herling A W, Quint M, Gerl M, Metz-Weidmann C, Haun G, Korn M
Sanofi-Aventis Deutschland GmbH, Science and Medical Affairs, TD Metabolism, Industriepark Hoechst, 65926 Frankfurt am Main, Germany.
Diabetologia. 2005 Dec;48(12):2622-30. doi: 10.1007/s00125-005-0025-2. Epub 2005 Nov 12.
AIMS/HYPOTHESIS: Insulin resistance in skeletal muscle is a hallmark of type 2 diabetes. Therefore, we sought to identify and validate genes involved in the development of insulin resistance in skeletal muscle.
Differentially regulated genes in skeletal muscle of male obese insulin-resistant, and lean insulin-sensitive Zucker diabetic fatty (ZDF) rats were determined using Affymetrix microarrays. Based on these data, various aspects of glucose disposal, insulin signalling and fatty acid composition were analysed in a muscle cell line overexpressing stearoyl-CoA desaturase 1 (SCD1).
Gene expression profiling in insulin-resistant skeletal muscle revealed the most pronounced changes in gene expression for genes involved in lipid metabolism. Among these, Scd1 showed increased expression in insulin-resistant animals, correlating with increased amounts of palmitoleoyl-CoA. This was further investigated in a muscle cell line that overexpressed SCD1 and accumulated lipids, revealing impairments of glucose uptake and of different steps of the insulin signalling cascade. We also observed differential effects of high-glucose and fatty acid treatment on glucose uptake and long-chain fatty acyl-CoA profiles, and in particular an accumulation of palmitoleoyl-CoA in cells overexpressing SCD1.
CONCLUSIONS/INTERPRETATION: Insulin-resistant skeletal muscle of ZDF rats is characterised by a specific gene expression profile with increased levels of Scd1. An insulin-resistant phenotype similar to that obtained by treatment with palmitate and high glucose can be induced in vitro by overexpression of SCD1 in muscle cells. This supports the hypothesis that elevated SCD1 expression is a possible cause of insulin resistance and type 2 diabetes.
目的/假设:骨骼肌胰岛素抵抗是2型糖尿病的一个标志。因此,我们试图识别并验证参与骨骼肌胰岛素抵抗发生发展的基因。
使用Affymetrix微阵列确定雄性肥胖胰岛素抵抗和瘦胰岛素敏感的Zucker糖尿病脂肪(ZDF)大鼠骨骼肌中差异调节的基因。基于这些数据,在过表达硬脂酰辅酶A去饱和酶1(SCD1)的肌肉细胞系中分析了葡萄糖处置、胰岛素信号传导和脂肪酸组成的各个方面。
胰岛素抵抗骨骼肌中的基因表达谱显示,脂质代谢相关基因的表达变化最为显著。其中,Scd1在胰岛素抵抗动物中表达增加,与棕榈油酰辅酶A含量增加相关。在过表达SCD1并积累脂质的肌肉细胞系中对此进行了进一步研究,结果显示葡萄糖摄取以及胰岛素信号级联反应的不同步骤均受损。我们还观察到高糖和脂肪酸处理对葡萄糖摄取和长链脂肪酰辅酶A谱的不同影响,特别是在过表达SCD1的细胞中棕榈油酰辅酶A的积累。
结论/解读:ZDF大鼠的胰岛素抵抗骨骼肌具有Scd1水平升高的特定基因表达谱特征。在肌肉细胞中过表达SCD1可在体外诱导出类似于用棕榈酸和高糖处理所获得的胰岛素抵抗表型。这支持了SCD1表达升高可能是胰岛素抵抗和2型糖尿病病因的假说。